Monday, January 17, 2022

ZyCoV-D

Covid vaccine exclusively for adolescents likely

MoHFW may approve Covid vaccine this month for those aged between 12 years and 18 years

Editorial: Boost to vaccination drive

Nod for Zydus Cadila'd Covid vaccine for children will help India ramp up its vaccination programme quickly

More Covid vaccines in pipeline

At least four to five more candidates in advanced stages of clinical trials and expected to get a nod from regulatory authorities

Zydus Cadila gets DCGI nod for Phase-3 clinical trials for Covid-19 vaccine

The Nation's first indigenously developed DNA vaccine candidate against COVID-19, ZyCoV-D, by M/s Zydus Cadila has been approved by Drugs Controller General of India (DCGI), for the conduct of the Phase III clinical trials

Gujarat: PM Modi reviews vaccine development at Zydus Cadila facility

Zydus Cadila has announced that the phase-I clinical trial of its vaccine candidate ZyCoV-D is over and it has commenced phase-II clinical trials from August.

PM Modi reaches Ahmedabad to review coronavirus vaccine development

Zydus Cadila has announced that the phase-I clinical trial of its vaccine candidate ZyCoV-D was over and it has commenced phase-II clinical trials from August.

PM Modi to review vaccine work in Ahmedabad, Pune and Hyderabad

Zydus Cadila had announced that the phase-I clinical trial of its vaccine candidate ZyCoV-D was over and it has commenced phase-II clinical trials from August.

Latest News

- Advertisement -